Skip to content
Screener

uniQure QURE Net Income

Net Income at other companies

Sarepta Therapeutics, Inc. logo
Sarepta Therapeutics, Inc.SRPT
-$4.89M-102%
Taysha Gene Therapies, Inc. logo
Taysha Gene Therapies, Inc.TSHA
-$42.41M-97.0%
PTC Therapeutics logo
PTC TherapeuticsPTCT
-$2.81M-100%
Design Therapeutics, Inc. logo
Design Therapeutics, Inc.DSGN
-$17.64M+0.4%
Candel Therapeutics, Inc. logo
Candel Therapeutics, Inc.CADL
-$8.86M-220%
Regenxbio logo
RegenxbioRGNX
$22.71M+132%

Other financials

Income statement

See full
Revenue$5.8M+11.0%
Gross profit$5.5M+19.2%
Operating income-$52.2M-19.0%
EPS (diluted)-$1.22-76.8%

Balance sheet

See full
Cash & equivalents$413.0M+62.8%
Total debt$62.8M-5.8%
Total equity$324.1M+8,195%
Total assets$985.1M+68.4%

Cash flow

See full
Operating cash flow-$28.6M+28.4%
CapEx$472.0K+81.5%
Free cash flow-$29.0M+27.7%

Valuation

See full
Market cap$3.15B+325%
Enterprise value$2.8B+406%
P/S168.5×+117×

Profitability

See full
Gross margin92.5%+4.6pp
Operating margin-1,071.5%-90.6pp
Net margin-1,350.7%-35.3pp
FCF margin-864.7%-194pp

Returns & leverage

See full
Return on equity-228.2%-11.6pp
Debt / equity0.2×
Current ratio10×0.0×

Where this comes from

Reported directly by uniQure in its filing.

Tagged under the XBRL concept us-gaap:NetIncomeLoss.

The source filing: uniQure’s 10-Q, filed July 29, 2026.

Filed
Jul 29, 2026, 7:17 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001104659-26-087815
Line itemThree months ended June 30, 2026Three months ended June 30, 2025Six months ended June 30, 2026Six months ended June 30, 2025
Other non-operating (losses), net(15,970)(12,201)
Loss before income tax expense$(79,218)$(37,294)$(132,265)$(80,435)
Income tax expense(1,841)(425)(2,329)(921)
Net loss$(81,059)$(37,719)$(134,594)$(81,356)
Other comprehensive loss:
Foreign currency translation gains / (losses), net1,634(5,098)(29)(6,103)
Total comprehensive loss$(79,425)$(42,817)$(134,623)$(87,459)
Loss per ordinary share - basic and diluted

Item 1.Financial Statements

FAQ

What is uniQure's net income?
uniQure (QURE) reported net income of -$81.06M in Q2 2026.
How has uniQure's net income changed year-over-year?
uniQure's net income decreased by 114.9% year-over-year, from -$37.72M to -$81.06M.
What is the long-term trend for uniQure's net income?
Over 4 years (2021 to 2025), uniQure's net income has grown at a -11.9% compound annual growth rate (CAGR), from $329.59M to -$198.97M.
What does net income mean?
The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.

Ask your AI about uniQure's net income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude